Risankizumab

Risankizumab is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis (a skin condition that causes raised, red, scaly patches on the skin). Risankizumab is a monoclonal antibody that works by blocking a certain protein (interleukin-23, or IL-23) that is believed to be involved in the overactive immune response that causes psoriasis. It is administered as an intravenous (IV) infusion given every 12 weeks after the initial loading dose.

Risankizumab is a medication used to treat certain chronic inflammatory conditions, including [1, 2, 3]:

• Crohn's disease: An inflammatory bowel disease (IBD) that causes inflammation of the lining of the digestive tract
• Psoriatic arthritis: A type of arthritis that affects some people with psoriasis, a skin condition characterized by red, scaly patches

How it Works:

• Belongs to a class of drugs called interleukin-23 (IL-23) inhibitors [1, 2].
• IL-23 is a protein involved in the immune system's inflammatory response [2].
• Risankizumab works by specifically blocking IL-23, thereby helping to reduce inflammation in the body [2, 3].

Benefits:

• Can help reduce symptoms of Crohn's disease, such as abdominal pain, diarrhea, and rectal bleeding [1, 3].
• May also improve symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling [1, 3].
• In some cases, it can help induce and maintain remission (inactive disease state) [3].

Dosage and Administration:

• Comes as an injection typically administered under the skin (subcutaneously) by a healthcare professional [1, 2].
• The specific dosage and frequency will depend on the condition being treated and your individual response to the medication, as determined by your doctor [1].

Safety and Side Effects:

• Generally well-tolerated, but some side effects may occur, including upper respiratory infections (common cold, sinusitis), headache, fatigue, injection site reactions [1, 2].
• There's a risk of increased infections due to the medication's suppression of the immune system [2].
• It's important to discuss any pre-existing health conditions or medications you are taking with your doctor before starting risankizumab to avoid potential interactions [1].

Important Notes:

• Risankizumab is not a cure for Crohn's disease or psoriatic arthritis, but it can help manage the symptoms and improve quality of life [3].
• Regular monitoring by your doctor is necessary while using risankizumab, including blood tests to assess for infections and other potential side effects [3].
• Risankizumab may not be suitable for everyone, particularly those with a weakened immune system or a history of severe infections [1].

Remember:

• This information is intended for general knowledge only and should not be a substitute for medical advice.
• Always consult your doctor about the appropriate treatment plan for Crohn's disease, psoriatic arthritis, or any other medical condition.